NASDAQ: BTCY - Biotricity, Inc.

半年間の収益性: -80.74%
セクタ: Healthcare

プロモーションスケジュール Biotricity, Inc.


会社について

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.


Цена ао 1.33
Выручка 0.000398
EBITDA -1.2E-5
P/S 76.27
P/BV -17.09
EV/EBITDA -2671.72
ISIN US09074H1041
Число акций ао 0.00866 млрд
Сайт https://www.biotricity.com
Валюта usd
IPO date 2016-02-18
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
1日あたりの価格変動: +1.72% (0.2556)
週ごとの価格変動: 0% (0.26)
月ごとの料金変更: -20.49% (0.327)
3ヶ月間の価格変動: -69.19% (0.844)
半年間の価格変動: -80.74% (1.35)
年間の価格変動: -87.85% (2.14)
3年間の価格推移: -90.58% (2.76)
5年間の価格推移: -55.93% (0.59)
年初からの価格変動: -72.63% (0.95)

過小評価

名前 意味 学年
P/S 1 9
P/BV -0.4031 0
P/E 0 0
EV/EBITDA -2.82 0
合計: 4.63

効率

名前 意味 学年
ROA, % -237.17 0
ROE, % 47.02 10
合計: 5

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -1.47 10
合計: 6.6

成長の衝動

名前 意味 学年
収益性 Revenue, % 761.67 10
収益性 Ebitda, % 81.23 9
収益性 EPS, % 378.63 10
合計: 6.6



スーパーバイザー 役職 支払い 生年
Dr. Waqaas Al-Siddiq Ph.D. Founder, President, CEO & Chairman 732k 1985 (39 年)
Mr. S. John Ayanoglou Chief Financial Officer 305.75k 1966 (58 年)
Dr. George N. Nikopoulos Director of Business Development N/A
Mr. Matt Zabel Vice President of Sales & Strategy N/A
Mr. Amir Ali Chief Development Officer N/A
Amjad Talpur Senior Director of Operations
Dr. Fareeha Siddiqui Senior Vice President of Healthcare Solutions

住所: United States, Redwood City. CA, 203 Redwood Shores Parkway - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.biotricity.com